SEC Form 4 · accession 0001261380-16-000083
IRIDEX CORP · IRIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald Steckel
Officer — VP, Operations
Period of report
May 17, 2016
Accepted (ET)
May 18, 2016 · 7:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001006045
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 17, 2016 | M | 2,083 | $3.99 | A | 68,958 | D | |
| Common StockF1 | May 17, 2016 | S | 2,083 | $12.8187 | D | 66,875 | D | |
| Common Stock | May 17, 2016 | M | 1,250 | $3.856 | A | 68,125 | D | |
| Common StockF1 | May 17, 2016 | S | 1,250 | $12.8187 | D | 66,875 | D | |
| Common StockF2 | May 17, 2016 | S | 1,250 | $12.7944 | D | 65,625 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option Right to BuyF3,F4 | $3.99 | May 17, 2016 | M | 2,083 | D | Apr 16, 2013 | Apr 16, 2019 | Common Stock | 2,083 | 0 | D |
| Stock Option Right to BuyF3,F5 | $3.856 | May 17, 2016 | M | 1,250 | D | Feb 1, 2013 | Dec 13, 2019 | Common Stock | 1,250 | 5,000 | D |
Explanation of responses
- F1The sales price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold, ranging from $12.67 to $12.97 per share. Upon request by the Commission staff, the Issuer, or a security holder of Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F2The sales price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold, ranging from $12.67 to $12.9 per share. Upon request by the Commission staff, the Issuer, or a security holder of Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F3This option was granted pursuant to IRIDEX Corporation's 2008 Equity Incentive Plan and is exempt to Rule 16b-3.
- F4The shares shall vest as follows: 12/48ths of the shares shall vest 12 months after the Vesting Commencement Date and 1/48th of the shares shall vest each month thereafter.
- F5The shares are subject to vesting according to the following schedule: 1/48th of the total number of shares vest each month.